[KRAS and bronchial adenocarcinoma. Between disappointments and hopes]

N Guibert1, M Ilie2, H Léna3

  • 1Unité d'oncologie cervico-thoracique-clinique des voies respiratoires, service de pneumologie, hôpital Larrey, université Paul-Sabatier, CHU de Toulouse, chemin de Pouvourville, 31059 Toulouse cedex, France.

Insights

KRAS mutations drive lung adenocarcinoma oncogenesis, but complex signaling hindered past therapies. New research into KRAS subtypes and synthetic lethality offers promising therapeutic avenues for lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer treatment has improved due to better understanding of oncogenesis and targeted therapies.
  • KRAS mutations are implicated in nearly one-third of lung adenocarcinomas, driving complex signaling pathways.
  • Previous inhibition strategies targeting KRAS or its effectors yielded disappointing results due to this complexity.

Purpose of the Study:

  • To review the epidemiological data and prognostic impact of KRAS mutations in non-small cell lung cancer.
  • To explore emerging therapeutic strategies based on distinct KRAS mutation subtypes and synthetic lethality.
  • To provide an overview of current and potential future drug treatments for KRAS-mutated lung cancer.

Main Methods:

  • Literature review of epidemiological data on KRAS mutations in lung cancer.
  • Analysis of recent research on KRAS subtypes and synthetic lethality mechanisms.
  • Compilation of data on drugs targeting KRAS mutations currently in clinical trials or under development.

Main Results:

  • KRAS mutations have a significant prognostic impact in non-small cell lung cancer.
  • Distinct KRAS mutation subtypes and their interactions with other genes are crucial for therapeutic development.
  • Emerging synthetic lethality approaches show promise for overcoming resistance to traditional KRAS-targeted therapies.

Conclusions:

  • Understanding KRAS mutation heterogeneity is key to developing effective lung cancer therapies.
  • New therapeutic strategies targeting specific KRAS alterations and synthetic lethality offer hope for improved patient outcomes.
  • Continued research into KRAS-driven lung cancer is essential for advancing treatment options.

Related Concept Videos

The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
8.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38
Trachea01:22

Trachea

The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
6.2K
Endoscopic Studies I: Bronchoscopy and Thoracoscopy01:30

Endoscopic Studies I: Bronchoscopy and Thoracoscopy

Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
909